ArticleScientific reports2026
An Attention-Enhanced ViT-HLNN Hybrid Ensemble Framework for Multi-Class Gastrointestinal Disease Classification.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- HybridCATNet: an explainable CNN-Transformer framework with early multi-channel fusion and uncertainty estimation for pneumonia detection from chest X-rays.Frontiers in digital health · 2026Article
- A severity-aware multi-task CNN-transformer framework for explainable diabetic foot ulcer triage and mobile deployment.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal (GI) diseases such as polyps, esophagitis, and ulcerative colitis pose significant diagnostic challenges due to subtle visual patterns. Early, accurate, and scalable diagnostic tools are essential for improving outcomes and streamlining care. In this study, we propose a hybrid deep learning framework for multi-class GI disease classification that integrates a Vision Transformer (ViT) with a Hierarchical Long-Short-Term-Memory Neural Network (HLNN), further enhanced through ensemble learning using Bagging and Stacking. This hybrid architecture captures both global dependencies and local spatial-temporal features in endoscopic imagery, enabling precise multi-class classification. The model was trained and validated on the Kvasir-v2 dataset, comprising over 8000 labelled endoscopic images across eight GI disease classes. The proposed method achieved up to 99.99% accuracy on the test set and 99.96% mean accuracy across tenfold cross-validation, with macro F1-scores exceeding 0.999, and Cohen's kappa of 0.994, indicating excellent agreement. Test set performance was evaluated on a fixed, class-stratified held-out test set (100 images per class) and reported as the mean across multiple training runs with different random seeds, ensuring statistical robustness. In comparative analysis, we demonstrated that the proposed hybrid model outperforms established baselines, including ViT-only, MobileNet-V2, EfficientNet-B0, ResNet-101, and NASNet-Large. Controlled ablation studies validate the individual and combined contributions of HLNN and ensemble strategies. Robustness was further confirmed under Gaussian noise, motion blur, and illumination shifts, with accuracy consistently above 96%. Zero-shot external evaluation on the independent GastroVision dataset and class-holdout testing on the held-out Polyps class further demonstrate generalization beyond the Kvasir-v2 training distribution. Robustness of Grad-CAM explanations was validated through a sanity check, correlation r = 0.91, and focused attention entropy 0.32, confirming stability under perturbations. These results highlight the potential of the proposed framework for robust and interpretable GI image classification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.